Director
DIN: 08755822
Ramkumar Dasharath Meti is currently associated with 2 companies in various capacities such as Individual Promoter and Director. They serve as a Director at ETHICLIN PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08755822.Ramkumar Dasharath Meti is currently involved in 2 different roles. Their most recent position is with BIOIRIS PHARMACEUTICALS PRIVATE LIMITED as a Director. The first company Ramkumar Dasharath Meti was appointed to as a director was ETHICLIN PRIVATE LIMITED. Ramkumar Dasharath Meti is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Ramkumar Dasharath Meti is currently associated with 2 companies in various capacities such as Individual Promoter and Director. They serve as a Director at ETHICLIN PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08755822.Ramkumar Dasharath Meti is currently involved in 2 different roles. Their most recent position is with BIOIRIS PHARMACEUTICALS PRIVATE LIMITED as a Director. The first company Ramkumar Dasharath Meti was appointed to as a director was ETHICLIN PRIVATE LIMITED. Ramkumar Dasharath Meti is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
1y 3m 8 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ETHICLIN PRIVATE LIMITED | Individual Promoter | 07-Jun-2020 |
| ETHICLIN PRIVATE LIMITED | Director | 07-Jun-2020 |
| BIOIRIS PHARMACEUTICALS PRIVATE LIMITED | Director | 20-Sep-2022 |
| BIOIRIS PHARMACEUTICALS PRIVATE LIMITED | Individual Promoter | 20-Sep-2022 |